Recent decades have seen a dramatic reduction in age-adjusted stroke-related mortality, presumably owing to better control of vascular risk factors, use of antithrombotic agents and improvements in acute stroke care. Here, we highlight a few developments in stroke prevention and acute care that have particularly influenced the care of patients.
This is a preview of subscription content, log in via an institution to check access.
References
Hacke, W. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317–1329 (2008).
IST-3 collaborative group. et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomized controlled trial. Lancet 379, 2352–2363 (2012).
Emberson, J. et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 384, 1929–1935 (2014).
Falk-Delgado, A., Kuntze Söderqvist, Å., Fransén, J. & Falk-Delgado, A. Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis. J. Neurointerv. Surg. http://dx.doi.org/10.1136/neurintsurg-2015-011835.
Prabhakaran, S., Ruff, I. & Bernstein, R. A. Acute stroke intervention: a systematic review. JAMA 313, 1451–1462 (2015).
Powers, W. J. et al. 2015 AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke http://dx.doi.org/10.1161/STR.0000000000000074.
Ruff, C. T. et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383, 955–962 (2014).
Kirchhof, P. et al. Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology/European Heart Rhythm Association/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation/American Heart Association/Heart Rhythm Society, and the Canadian Cardiovascular Society. Eur. Heart J. 34, 1471–1474 (2013).
Sanna, T. et al. Cryptogenic stroke and underlying atrial fibrillation. N. Engl. J. Med. 370, 2478–2486 (2014).
Feigin, V. L. et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 383, 245–254 (2014).
Acknowledgements
J.G.R. and R.L.S. have received research salary support from the NIH/NINDS (1R01NS29993, R01 NS40807 and and 1R01NS084288).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.G.R. has received research support for MaRISS Study and honoraria from Genentech for a steering committee role, and honoraria and stock from Vycor NovaVision for a scientific advisory board role. R.L.S. has consulted for Boehringer Ingelheim as co-chair of the RESPECT-ESUS trial with dabigatran versus aspirin for secondary stroke prevention.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Romano, J., Sacco, R. Progress in acute ischaemic stroke treatment and prevention. Nat Rev Neurol 11, 619–621 (2015). https://doi.org/10.1038/nrneurol.2015.199
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2015.199
- Springer Nature Limited
This article is cited by
-
Risk factors of acute cerebral infarction in patients with primary hypertension
Irish Journal of Medical Science (1971 -) (2023)
-
Recent Trends in Clot Retrieval Devices: A Review
Cardiology and Therapy (2017)
-
Regulatory T Cell Therapy for Ischemic Stroke: how far from Clinical Translation?
Translational Stroke Research (2016)